Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales

By Yahoo! Finance | Sep 25, 2024 at 11:34 AM EST

Immunocore Holdings plc (NASDAQ:IMCR) is a biotech company trading near its 52-week low despite solid financial performance. However, uncertainty over clinical trials and high short interest make it one of the worst stocks to buy according to short sellers.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.